Table:
begin	end	state
1	6	cytoplasmic
7	26	transmembrane
27	48	non-cytoplasmic
49	71	transmembrane
72	79	cytoplasmic
80	99	transmembrane
100	104	non-cytoplasmic
105	129	transmembrane
130	140	cytoplasmic
141	161	transmembrane
162	166	non-cytoplasmic
167	188	transmembrane
189	234	cytoplasmic
235	256	transmembrane
257	268	non-cytoplasmic
269	288	transmembrane
289	297	cytoplasmic
298	317	transmembrane
318	322	non-cytoplasmic
323	347	transmembrane
348	357	cytoplasmic
358	378	transmembrane
379	388	non-cytoplasmic
389	409	transmembrane
410	431	cytoplasmic

Input:
>BPHYT_RS11295
MTSSLAIRRWWTIMPIVFITYSLAYLDRANYGFASAAGINQDLGISKGLSSLIGALFFLG
YFFFQIPGAIYAERRSVKKLVFWSLILWGACASLTGMVSNIPSLMVIRFVLGVVEAAVMP
AMLIFISNWFTKSERSRANTFLILGNPVTVLWMSVVSGYLVHSFGWRHMFIAEGAPAILW
AVCWWFIVKDKPQQVSWLTQQQKDDLAETLRAEQAAIKPVRNYSDAFKTPAVIKLCAQYF
CWSIGVYGFVLWLPSILKNGSTLGMVETGWLSALPYLAATIAMLAASWASDKLNRRKVFV
WPFLLVGAVAFAASYALGSTHFWLSYALLVIAGAAMYAPYGPFFAIVPELLPKNVAGGAM
ALINSMGALGSFVGSYVVGYLNGATGSPAASYAFMSVALVTAVILTLIVKPQQQESSNAA
TARHPVARKIS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server